Lamotrigine-induced DRESS syndrome in a patient with mood disorder and NAGS deficiency: A case report
DOI:
https://doi.org/10.37609/srinmed.64Keywords:
N-acetyl glutamate synthase deficiency, DRESS syndrome, Lamotrigine, Mood disorder, TreatmentAbstract
N-acetyl glutamate synthase (NAGS) deficiency is a very rare autosomal recessive metabolic disease that affects the urea cycle and can cause serious morbidity and mortality. In these cases, mood disorders are rare, and potential side effects are important in the treatment of neurological and psychiatric conditions occurring due to the existing enzyme deficiency. In this study, a case of NAGS deficiency, epilepsy, and mood disorder, as well as drug rash with eosinophilia and systemic symptoms (DRESS) syndrome after lamotrigine use, is presented.
Downloads
References
. Gropman AL, Summar M, Leonard JV. Neurological implications of urea cycle disorders. J Inherit Metab Dis. 2007 306:865-879. https://doi.org/10.1007/s10545-007-0709-5.
Bachmann C, Krahenbuhl S, Colombo JP, Schubiger G, Jaggi KH, Tonz O. N-Acetylglutamate synthetase deficiency: a disorder of ammonia detoxication. N Engl J Med. 1981 304(9);543. https://doi.org/10.1056/NEJM198102263040917.
Summar ML, Koelker S, Freedenberg D, Le Mons C, Haberle J, Lee HS, et al; European Registry and Net-work for Intoxication Type Metabolic Diseases (E-IMD). The incidence of urea cycle disorders. Mol Genet Metab. 2013 Sep-Oct;110(1-2):179-180. https://doi.org/10.1016/j.ymgme.2013.07.008
Krivitzky L, Babikian T, Lee HS, Thomas NH, Burk-Paull KL, Batshaw ML. Intellectual, adaptive, and behav-ioral functioning in children with urea cycle disorders. Pediatr Res. 2009 Jul;66(1):96-101. doi: 10.1203/PDR.0b013e3181a27a16..
Waisbren SE, Stefanatos AK, Kok TMY, Ozturk-Hismi B. Neuropsychological attributes of urea cycle disor-ders: A systematic review of the literature. J Inherit Metab Dis. 2019 Nov;42(6):1176-1191. doi: 10.1002/jimd.12146.
Kenneson A, Singh RH. Presentation and management of N‐acetylglutamate synthase deficiency: a re-view of the literature. Orphanet J Rare Dis. 2020 Oct 9;15(1):279. doi: 10.1186/s13023-020-01560-z.
Seminara J, Tuchman M, Krivitzky L, Krischer J, Lee HS, Lemons C, et al. Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium. Mol Genet Metab. 2010;100 Suppl 1(Suppl 1):S97-105. doi: 10.1016/j.ymgme.2010.01.014.
Khan Z, Warrier V, Muhammad SA, Gupta A, Yousif Y, Khan A et al. Drug reaction with eosinophilia and systemic symptoms syndrome in a patient taking lamotrigine: A case report based literature review. Cu-reus. 2022 Feb 18;14(2):e22359. doi: 10.7759/cureus.22359.
Substance Abuse and Mental Health Services Administration. (2016). Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t23/
Al Kaabi EH, El-Hattab AW. N-acetylglutamate synthase deficiency: Novel mutation associated with neo-natal presentation and literature review of molecular and phenotypic spectra. Mol Genet Metab Rep. 2016 Aug 17;8:94-98. doi: 10.1016/j.ymgmr.2016.08.004.
Bélanger-Quintana A, Martínez-Pardo M, García MJ, Wermuth B, Torres J, Pallarés E, et al. Hyperammo-naemia as a cause of psychosis in an adolescent. Eur J Pediatr 2003 Nov;162(11):773-5. doi: 10.1007/s00431-002-1126-2.
Bozacı AE, Göksoy E, Ünal AT, Albayrak HM, Taş İ et al. Evaluation of the neurodevelopmental status for urea cycle disorders: Based on clinical experience. J Pediatr Res. 2023 Sep 14;10(3):182-194. doi: 10.4274/jpr.galenos.2023.96992.
Waisbren SE, Gropman AL, Batshaw ML. Improving long term outcomes in urea cycle disorders‐report from the urea cycle disorders consortium. J Inherit Metab Dis. 2016 Jul;39(4):573-84. doi: 10.1007/s10545-016-9942-0.
Plecko, B., Erwa, W., Wermuth, B. Partial n-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with n-carbamylglutamate. Europ. J. Pediat. 1998 Dec;157(12):996-8. doi: 10.1007/s004310050985.
Kido J, Matsumoto S, Ito T, Hirose S, Fukui K, Kojima-Ishii K et al. Physical, cognitive, and social status of patients with urea cycle disorders in Japan. Mol Genet Metab Rep. 2021 Feb 7;27:100724. doi: 10.1016/j.ymgmr.2021.100724.
Peoc’h K, Damaj L, Pelletier R, Lefèvre C, Dubourg C, Denis MC, et al. Early care of N-acetyl glutamate synthase (NAGS) deficiency in three infants from an inbred family. Mol Genet Metab Rep. 2020 Jan 24;22:100558. doi: 10.1016/j.ymgmr.2019.100558.
Häberle J. Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyper-ammonemia. Expert. Rev. Endocrinol. Metab. 2012 May;7(3):263-271. doi: 10.1586/eem.12.17.
NORD (National Organization for Rare Disorders). N‐Acetylglutamate synthetase deficiency. Last updat-ed: 9/26/2024. https://rarediseases.org/rare-diseases/n-acetylglutamate-synthetase-deficiency/
Sattar Y, Wasiq S, Yasin W, Khan AM, Adnan M, Shrestha S, et al. Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report. Cureus. 2018 Sep 12;10(9):e3292. doi: 10.7759/cureus.3292.
Serrano M, Martins C, Pérez-Dueñas B, Gómez-López L, Murgui E, Fons C, et al. Neuropsychiatric mani-festations in late-onset urea cycle disorder patients. J Child Neurol. 2010 Mar;25(3):352-8. doi: 10.1177/0883073809340696.
Lin CH, Lin SS, Hong SY, Chen CH, Chou IC. Lamotrigine induced DRESS Syndrome in a child: A case re-port and literature review. Children (Basel). 2021 Nov 19;8(11):1063. doi: 10.3390/children8111063.
Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019 Jul;68(3):301-308. doi: 10.1016/j.alit.2019.03.006.
Clark A, St Clair B. Severe cutaneous adverse reactions associated with high-dose lamotrigine for mood disorders: A case series. Innov Pharm. 2022 Dec 12;13(2):10.24926/iip.v13i2.4541. doi: 10.24926/iip.v13i2.4541.
Hama N, Abe R, Gibson A, Phillips EJ. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022 May;10(5):1155-1167.e5. doi: 10.1016/j.jaip.2022.02.004.
Manieri E, Dondi A, Neri I, Lanari M. Drug rash with eosinophilia and systemic symptoms (DRESS) syn-drome in childhood: a narrative review. Front Med (Lausanne). 2023 Jul 28;10:1108345. doi: 10.3389/fmed.2023.1108345.
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007 Mar;156(3):609-11. doi: 10.1111/j.1365-2133.2006.07704.x.
Musette P, Janela B. New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Patho-physiology. Front Med (Lausanne). 2017 Dec 4;4:179. doi: 10.3389/fmed.2017.00179. eCollection 2017.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Scientific Reports in Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal and content of this website is licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allows users to copy, distribute and transmit unmodified article, and make noncommercial use of the article. The CC BY license permits non-commercial re-use of an open access article, as long as the author is properly attributed.
